Recent Research Analysts’ Ratings Changes for Envista (NVST)

A number of research firms have changed their ratings and price targets for Envista (NYSE: NVST):

  • 11/7/2026 – Envista was downgraded by Wall Street Zen from “buy” to “hold”.
  • 11/5/2026 – Envista had its “hold” rating reaffirmed by Needham & Company LLC.
  • 11/5/2026 – Envista had its price target raised by UBS Group from $27.00 to $29.00. They now have a “neutral” rating on the stock.
  • 11/3/2026 – Envista had its “hold (c)” rating reaffirmed by Weiss Ratings.
  • 10/15/2026 – Envista was downgraded by Robert W. Baird from “outperform” to “neutral”. They now have a $26.00 price target on the stock, down from $34.00.
  • 10/15/2026 – Envista was downgraded by Robert W. Baird from “outperform” to “neutral”. They now have a $26.00 price target on the stock, down from $34.00.
  • 10/14/2026 – Envista had its price target lowered by Leerink Partners from $35.00 to $32.00. They now have an “outperform” rating on the stock.
  • 10/9/2026 – Envista had its price target lowered by Piper Sandler from $28.00 to $26.00. They now have a “neutral” rating on the stock.
  • 10/5/2026 – Envista was downgraded by Zacks Research from “strong-buy” to “hold”.
  • 9/28/2026 – Envista had its price target lowered by BMO Capital Markets from $29.00 to $26.00. They now have a “market perform” rating on the stock.
  • 9/18/2026 – Envista had its “neutral” rating reaffirmed by Piper Sandler. They now have a $28.00 price target on the stock.
  • 9/18/2026 – Envista had its price target lowered by UBS Group from $30.00 to $27.00. They now have a “neutral” rating on the stock.
  • 9/18/2026 – Envista had its “hold” rating reaffirmed by Needham & Company LLC.

Envista Stock Down 1.0%

Shares of NYSE:NVST traded down $0.24 during mid-day trading on Tuesday, hitting $23.79. 833,137 shares of the company traded hands, compared to its average volume of 2,933,892. The stock has a market cap of $3.81 billion, a P/E ratio of 6.15, a P/E/G ratio of 1.17 and a beta of 0.94. The stock has a 50-day moving average price of $24.13 and a two-hundred day moving average price of $25.77. Envista Holdings Corporation has a 12-month low of $18.77 and a 12-month high of $30.42. The company has a current ratio of 2.45, a quick ratio of 2.10 and a debt-to-equity ratio of 0.46.

Envista (NYSE:NVST – Get Free Report) last posted its quarterly earnings data on Wednesday, November 4th. The company reported $0.40 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.36 by $0.04. Envista had a net margin of 22.01% and a return on equity of 8.26%. The firm had revenue of $691.50 million for the quarter, compared to the consensus estimate of $688.74 million. During the same period in the previous year, the firm earned $0.32 EPS. The business’s revenue for the quarter was up 3.2% compared to the same quarter last year. On average, equities research analysts forecast that Envista Holdings Corporation will post 1.56 earnings per share for the current year.

Insider Buying and Selling

In other Envista news, SVP Mischa Reis sold 8,000 shares of the business’s stock in a transaction dated Thursday, August 20th. The shares were sold at an average price of $27.50, for a total value of $220,000.00. Following the transaction, the senior vice president directly owned 27,321 shares in the company, valued at $751,327.50. The trade was a 22.65% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.99% of the company’s stock.

Envista Holdings Corporation is a dental products and technology company that develops and supplies tools and services for dental professionals. Its offerings span implant dentistry, orthodontics, digital imaging, restorative care and other clinical applications. The company’s products include dental implants and related treatment systems, orthodontic brackets and clear aligners, imaging equipment and software, and restorative and endodontic materials. Its brands include Nobel Biocare, Ormco, DEXIS, Kerr and KaVo.

Read More

Receive News & Ratings for Envista Holdings Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista Holdings Corporation and related companies with MarketBeat.com's FREE daily email newsletter.